Florian E M Herrmann, Amar Taha, Mary Rezk, Susanne J Nielsen, Andreas Martinsson, Emma C Hansson, Gerd Juchem, Christian Hagl, Anders Jeppsson
{"title":"冠状动脉搭桥术术后早期与晚期新发心房颤动的预后。","authors":"Florian E M Herrmann, Amar Taha, Mary Rezk, Susanne J Nielsen, Andreas Martinsson, Emma C Hansson, Gerd Juchem, Christian Hagl, Anders Jeppsson","doi":"10.1161/JAHA.125.043026","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>It is unclear whether new-onset postoperative atrial fibrillation (POAF) early after coronary artery bypass grafting (CABG) is associated with a similar risk of adverse outcomes as new-onset atrial fibrillation occurring later after CABG.</p><p><strong>Methods: </strong>All patients treated with CABG in Sweden from 2007 to 2020 were investigated. Individual patient data from SWEDEHEART (Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies) registry and 3 other prospective national registries were merged. The adjusted incidences of all-cause mortality, ischemic stroke, any thromboembolism, heart failure hospitalization, and major bleeding within 12 months after debut of POAF (AF occurring before hospital discharge) or Late AF (new-onset AF occurring between 3 months and 3 years after CABG) were compared by multivariable Poisson regression analysis, adjusted for time-updated patient characteristics and comorbidities.</p><p><strong>Results: </strong>Out of 35 329 patients, 10 609 (30.0%) developed POAF and 628 (2.5%) developed Late AF. The crude mortality rate was lower in patients with POAF than in patients with Late AF (1.88 [95% CI, 1.63-2.17] versus 9.08 [95% CI, 6.92-11.82] per 100 patient-years). The adjusted incidence rate ratios for all-cause mortality (2.91 [95% CI, 2.10-3.95]); ischemic stroke (1.70 [95% CI, 1.15-2.44]); any thromboembolism (1.59 [95% CI, 1.11-2.22]), heart failure hospitalization (1.61 [95% CI, 1.19-2.12]); and major bleeding (1.73 [95% CI, 1.24-2.36]) were higher in patients with Late AF.</p><p><strong>Conclusions: </strong>POAF was associated with a markedly lower risk for morbidity and mortality than late new-onset AF after CABG. POAF and late new-onset AF after CABG are 2 different clinical entities of AF that may require different treatment strategies.</p>","PeriodicalId":54370,"journal":{"name":"Journal of the American Heart Association","volume":" ","pages":"e043026"},"PeriodicalIF":5.3000,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Outcomes in Early Postoperative Versus Late New-Onset Atrial Fibrillation After Coronary Artery Bypass Grafting.\",\"authors\":\"Florian E M Herrmann, Amar Taha, Mary Rezk, Susanne J Nielsen, Andreas Martinsson, Emma C Hansson, Gerd Juchem, Christian Hagl, Anders Jeppsson\",\"doi\":\"10.1161/JAHA.125.043026\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>It is unclear whether new-onset postoperative atrial fibrillation (POAF) early after coronary artery bypass grafting (CABG) is associated with a similar risk of adverse outcomes as new-onset atrial fibrillation occurring later after CABG.</p><p><strong>Methods: </strong>All patients treated with CABG in Sweden from 2007 to 2020 were investigated. Individual patient data from SWEDEHEART (Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies) registry and 3 other prospective national registries were merged. The adjusted incidences of all-cause mortality, ischemic stroke, any thromboembolism, heart failure hospitalization, and major bleeding within 12 months after debut of POAF (AF occurring before hospital discharge) or Late AF (new-onset AF occurring between 3 months and 3 years after CABG) were compared by multivariable Poisson regression analysis, adjusted for time-updated patient characteristics and comorbidities.</p><p><strong>Results: </strong>Out of 35 329 patients, 10 609 (30.0%) developed POAF and 628 (2.5%) developed Late AF. The crude mortality rate was lower in patients with POAF than in patients with Late AF (1.88 [95% CI, 1.63-2.17] versus 9.08 [95% CI, 6.92-11.82] per 100 patient-years). The adjusted incidence rate ratios for all-cause mortality (2.91 [95% CI, 2.10-3.95]); ischemic stroke (1.70 [95% CI, 1.15-2.44]); any thromboembolism (1.59 [95% CI, 1.11-2.22]), heart failure hospitalization (1.61 [95% CI, 1.19-2.12]); and major bleeding (1.73 [95% CI, 1.24-2.36]) were higher in patients with Late AF.</p><p><strong>Conclusions: </strong>POAF was associated with a markedly lower risk for morbidity and mortality than late new-onset AF after CABG. POAF and late new-onset AF after CABG are 2 different clinical entities of AF that may require different treatment strategies.</p>\",\"PeriodicalId\":54370,\"journal\":{\"name\":\"Journal of the American Heart Association\",\"volume\":\" \",\"pages\":\"e043026\"},\"PeriodicalIF\":5.3000,\"publicationDate\":\"2025-10-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the American Heart Association\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1161/JAHA.125.043026\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/9/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Heart Association","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/JAHA.125.043026","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/30 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Outcomes in Early Postoperative Versus Late New-Onset Atrial Fibrillation After Coronary Artery Bypass Grafting.
Background: It is unclear whether new-onset postoperative atrial fibrillation (POAF) early after coronary artery bypass grafting (CABG) is associated with a similar risk of adverse outcomes as new-onset atrial fibrillation occurring later after CABG.
Methods: All patients treated with CABG in Sweden from 2007 to 2020 were investigated. Individual patient data from SWEDEHEART (Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies) registry and 3 other prospective national registries were merged. The adjusted incidences of all-cause mortality, ischemic stroke, any thromboembolism, heart failure hospitalization, and major bleeding within 12 months after debut of POAF (AF occurring before hospital discharge) or Late AF (new-onset AF occurring between 3 months and 3 years after CABG) were compared by multivariable Poisson regression analysis, adjusted for time-updated patient characteristics and comorbidities.
Results: Out of 35 329 patients, 10 609 (30.0%) developed POAF and 628 (2.5%) developed Late AF. The crude mortality rate was lower in patients with POAF than in patients with Late AF (1.88 [95% CI, 1.63-2.17] versus 9.08 [95% CI, 6.92-11.82] per 100 patient-years). The adjusted incidence rate ratios for all-cause mortality (2.91 [95% CI, 2.10-3.95]); ischemic stroke (1.70 [95% CI, 1.15-2.44]); any thromboembolism (1.59 [95% CI, 1.11-2.22]), heart failure hospitalization (1.61 [95% CI, 1.19-2.12]); and major bleeding (1.73 [95% CI, 1.24-2.36]) were higher in patients with Late AF.
Conclusions: POAF was associated with a markedly lower risk for morbidity and mortality than late new-onset AF after CABG. POAF and late new-onset AF after CABG are 2 different clinical entities of AF that may require different treatment strategies.
期刊介绍:
As an Open Access journal, JAHA - Journal of the American Heart Association is rapidly and freely available, accelerating the translation of strong science into effective practice.
JAHA is an authoritative, peer-reviewed Open Access journal focusing on cardiovascular and cerebrovascular disease. JAHA provides a global forum for basic and clinical research and timely reviews on cardiovascular disease and stroke. As an Open Access journal, its content is free on publication to read, download, and share, accelerating the translation of strong science into effective practice.